4 Deaths Tied to Mushrooms; RSV Vax Wrongful Death Lawsuit; Kenya Ebola Plan Halted

Note that some links may require registration or subscription.

An outbreak linked to wild mushroom foraging in California in 2025-2026 resulted in 39 cases of amatoxin mushroom poisonings, three liver transplants, and four deaths. (Morbidity and Mortality Weekly Report)

HHS General Counsel Mike Stuart’s investments are under scrutiny. (NOTUS)

The White House has yet to release the doctor’s report from President Trump’s recent physical, as has been traditionally done in the past. (NBC News)

In a lawsuit against the U.S. government, the families of two Black infants say their children were unknowingly enrolled in a respiratory syncytial virus vaccine trial in the 1960s and died shortly after receiving the investigational shot. (New York Times)

All of the measles patients hospitalized early in the 2025 west Texas outbreak were unvaccinated or had unknown vaccination status, 70% developed pneumonia and hypoxia, and one patient died. (Morbidity and Mortality Weekly Report)

HHS issued a final rule aimed at overhauling the No Surprises Act’s independent dispute resolution process for out-of-network claims.

California’s attorney general sued the genetic testing company formerly known as 23andMe, alleging it failed to protect sensitive user data in a 2023 breach that affected nearly 7 million people across the country. (AP)

U.S. street drug fatalities dropped 14% nationwide in 2025 compared with 2024, though rates rose in some Western states. (NPR)

Aid supplies reached the heart of Congo’s Ebola outbreak, as health workers struggle to contain the virus. (AP, NPR)

A court in Kenya suspended the U.S. plan to establish a quarantine facility for Americans exposed to Ebola, following a backlash by medical workers and activists. (AP)

The Infectious Diseases Society of America slammed the plan.

The facility had been expected to open Friday, with U.S. patients who fell sick sent to Europe rather than the U.S. (NBC News)

Meanwhile, an American reporter who had been in Uganda recently said she didn’t undergo any screening or questioning upon her return to the U.S. (The Hill)

The administration will soon allow Americans exposed to hantavirus to return home from the Nebraska quarantine facility, though they will need to remain under 24/7 monitoring for 3 more weeks. (CNN)

CVS Caremark will once again cover Eli Lilly’s weight-loss drug tirzepatide (Zepbound) following patient backlash. (NBC News)

In related news, is Eli Lilly’s investigational GLP-1 drug retatrutide too powerful? (Washington Post)

The FDA approved a label update for guselkumab (Tremfya) to indicate the drug can inhibit progression of structural joint damage in psoriatic arthritis, Johnson & Johnson announced.

As predictive medicine advances, legal scholars warn that old federal guidelines protect employers from having to make accommodations for a person’s future health risk. (New York Times)

NASCAR driver Kyle Busch’s death certificate revealed he’d been battling bacterial pneumonia for “days to weeks” and that his sepsis triggered disseminated intravascular coagulation followed by hemorrhagic shock. (USA Today)

A Canadian man accused of selling lethal substances online to people who used them to end their own lives is expected to plead guilty to 14 counts of counseling or aiding suicide. (AP)